Company Filing History:
Years Active: 2007-2012
Title: Shimon Marom: Innovator in Electrophysiological Research
Introduction
Shimon Marom is a prominent inventor based in Haifa, Israel. He has made significant contributions to the field of electrophysiology, particularly in the development of polynucleotides and polypeptides related to human ion channels. With a total of 4 patents to his name, Marom's work has the potential to impact medical treatments for various conditions.
Latest Patents
One of Marom's latest patents focuses on polynucleotides and polypeptides of human KV1.3. This invention includes an isolated polypeptide that comprises a first amino acid sequence that is at least 90% homologous to specific amino acid coordinates. Additionally, it features a tryptophan residue and a second amino acid sequence that is also at least 90% homologous to another set of coordinates. The patent outlines the uses of these polypeptides in treating medical conditions associated with ion channel insufficiency. Another significant patent involves nucleic acid constructs and cells, which provide methods for modifying the electrophysiological function of excitable tissues. This invention includes polynucleotide expression constructs and methods for treating diseases caused by dysfunction in excitable tissues.
Career Highlights
Shimon Marom is currently associated with Genegrafts Ltd., where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding of ion channels and their role in various medical conditions.
Collaborations
Marom collaborates with notable colleagues, including Yair Feld and Lior Gepstein. Their combined expertise enhances the research efforts at Genegrafts Ltd. and fosters innovation in the field.
Conclusion
Shimon Marom's contributions to electrophysiological research and his innovative patents position him as a key figure in the scientific community. His work not only advances our understanding of ion channels but also holds promise for future medical applications.